Related content

Defining clinically relevant molecular subsets of lung cancer

By Pao William  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 11-15

Springer Publishing Company

Access to resources Recommend Favorite

Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer

By                        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 2, 2012-01 ,pp. : 226-230

Spandidos Publications

Access to resources Recommend Favorite

Small-Cell Lung Cancer in the Elderly: Is Age of Patient a Relevant Factor?

By Jara Carlos   Gómez-Aldaraví Jose L.   Tirado Raimundo   Meseguer Victoria A.   Alonso Carmen   Fernández Antonio  

Acta Oncologica, Vol. 38, Iss. 6, 1999-09 ,pp. : 781-786

Informa Healthcare

Access to resources Recommend Favorite

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer

By                

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 323-329

Spandidos Publications

Access to resources Recommend Favorite

Clinical relevance of molecular markers in lung cancer

By Iyengar P.   Tsao M.-S.  

Surgical Oncology, Vol. 11, Iss. 4, 2002-12 ,pp. : 167-179

Elsevier

Access to resources Recommend Favorite